Immunotherapy and evolving approaches for basal cell carcinoma

touchEXPERT OPINIONS for touchONCOLOGY

Listen to leading experts discuss evolving treatment options for patients with advanced basal cell carcinoma, and how novel immunotherapeutic approaches within the emerging clinical study landscape may improve patient care.

The experts

• Prof. Axel Hauschild, University Hospital Schleswig-Holstein, Kiel, Germany
• Dr Emily Ruiz, Brigham and Women’s Hospital, Boston, MA, USA
• Prof. Ketty Peris, Catholic University of Rome, Rome, Italy

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. This activity is jointly provided by USF Health and touchIME.